Sacha Loiseau, Ph.D., Chairman and CEO of Mauna Kea Technologies, commented: "The selection of the CLIMB study for the ASGE Presidential Plenary Session at DDW 2026 represents a major recognition for ...
Results build on new CLIMB study data recently presented at Digestive Disease Week ® (DDW) 1 confirming Cellvizio ® ’s unmatched accuracy in pancreatic cyst diagnosis PARIS & BOSTON--(BUSINESS WIRE)-- ...
PARIS & BOSTON, March 11, 2026--(BUSINESS WIRE)--Regulatory News: Mauna Kea Technologies (Euronext Growth: ALMKT), inventor of Cellvizio, the multidisciplinary probe and needle-based confocal laser ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results